Global Partners May End Broad Covid Vaccination Effort in Developing Countries
Covax has had to renegotiate its contracts with four suppliers of vaccines, to reduce them by between 400 and 600 million doses. Four hundred million doses from Pfizer that were coming as a donation from the United States government have been converted into future options available in 2023. “We did not massively overbuy,” Dr. Berkley…